CDK inhibitors in advanced HR+ Her 2-breast cancer: A systematic review and meta-analysis of randomized trials.

Messina, C; Messina, M; Buzzatti, G; Cattrini, C; Cerbone, L; Latocca, MM

JOURNAL OF CLINICAL ONCOLOGY, 2018; 36 (15):